These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 38070541

  • 21. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
    Raone B, Patrizi A, Gurioli C, Gazzola A, Ravaioli GM.
    Photodermatol Photoimmunol Photomed; 2018 Sep; 34(5):302-306. PubMed ID: 29533483
    [Abstract] [Full Text] [Related]

  • 22. UVB phototherapy and skin cancer risk: a review of the literature.
    Lee E, Koo J, Berger T.
    Int J Dermatol; 2005 May; 44(5):355-60. PubMed ID: 15869531
    [Abstract] [Full Text] [Related]

  • 23. The challenge of follow-up in narrowband ultraviolet B phototherapy.
    Diffey BL, Farr PM.
    Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
    [Abstract] [Full Text] [Related]

  • 24. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA, Marcil I, Stern RS.
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk of Skin Cancer with Phototherapy in Moderate-to-Severe Psoriasis: An Updated Systematic Review.
    Thatiparthi A, Martin A, Liu J, Wu JJ.
    J Clin Aesthet Dermatol; 2022 Jun; 15(6):68-75. PubMed ID: 35783563
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E, Erbil AH, Kurumlu Z, Taştan HB, Etikan I.
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [Abstract] [Full Text] [Related]

  • 28. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
    Ko MJ, Tsai WC, Tsai PH, Hsu LY, Chien KL, Wu HY.
    J Am Acad Dermatol; 2023 Sep; 89(3):496-503. PubMed ID: 37236426
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Risk of skin cancers in mycosis fungoides patients receiving PUVA therapy: A real-life experience from a single tertiary center.
    Doğan PE, Akay BN, Vural S, Arı C, Yılmaz TE, Şanlı H.
    Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):428-434. PubMed ID: 36967646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM.
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [Abstract] [Full Text] [Related]

  • 33. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H.
    Dermatology; 1996 Apr; 193(3):185-91. PubMed ID: 8944338
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
    Ju HJ, Han JH, Kim MS, Lee SH, Shin JW, Choi M, Jeong KH, Han TY, Choi CW, Lee HJ, Oh SH, Lee SH, Kim DH, Shin J, Lee JH, Kim SS, Kang HY, Chang SE, Kim JS, Lee DY, Choi GS, Suh DH, Chan Kim Y, Park CJ, Kim KH, Lee AY, Chan Park K, Lee MH, Bae JM, Korean Society for Vitiligo and the Korean Society for Photomedicine.
    J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
    [Abstract] [Full Text] [Related]

  • 36. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 37. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B, Sigurgeirsson B, Tegner E, Larkö O, Johannesson A, Berne B, Ljunggren B, Andersson T, Molin L, Nylander-Lundqvist E, Emtestam L.
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [Abstract] [Full Text] [Related]

  • 38. UVB doses in maintenance psoriasis phototherapy versus solar UVB exposure.
    Schothorst AA, Slaper H, Schouten R, Suurmond D.
    Photodermatol; 1985 Aug; 2(4):213-20. PubMed ID: 4059077
    [Abstract] [Full Text] [Related]

  • 39. Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris.
    Werfel T, Holiangu F, Niemann KH, Schmerling O, Lüllau F, Zedler A, Sträter HD, Niebuhr M.
    Br J Dermatol; 2015 Mar; 172(3):746-53. PubMed ID: 25307476
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.